Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells

Immunology Letters

Volumn 91, Issue 2-3, 2004, Pages 205-211

  Roeske Nielsen, A ^a,c   Fredman, P ^b   Mansson, J E ^b   Bendtzen, K ^c   Buschard, K ^a  

^a Kommunehospitalet ^*  (Denmark)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Rigshospitalet   (Denmark)

Author keywords

Beta galactosylceramide purified from pig brain; Beta galactosylceramide 3 O sulfate purified from pig brain; ELISA; Enzyme linked immunosorbent assay; GalCer; IL; Interleukin; MIP 1alpha; Native sulfatide; TNF alpha; Tumor necrosis factor alpha

Indexed keywords

BETA GALACTOSYLCERAMIDE; CHEMOKINE; CYTOKINE; GALACTOSYLCERAMIDE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SULFATIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CELL; BRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOASSAY; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SWINE;

ADULT; ANIMALS; BLOOD CELLS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; FEMALE; GALACTOSYLCERAMIDES; HUMANS; MALE; MIDDLE AGED; SULFOGLYCOSPHINGOLIPIDS; SWINE;

EID: 1542272478     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2003.12.010     Document Type: Article

References (28)

1. Svennerholm L., Bostrom K., Fredman P., Jungbjer B., Mansson J.E., Rynmark B.M. Biochim. Biophys. Acta. 1128:1992;1-7.
2. Buschard K., Josefsen K., Horn T., Larsen S., Fredman P. APMIS. 101:1993;963-970.
3. Fredman P., Mansson J.E., Rynmark B.M., Josefsen K., Ekblond A., Halldner L.et al. Glycobiology. 10:2000;39-50.
4. Osterbye T., Jorgensen K.H., Fredman P., Tranum-Jensen J., Kaas A., Brange J.et al. Glycobiology. 11:2001;473-479.
5. Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J.H., Dinarello C.A., Svenson M. Science. 232:1986;1545-1547.
6. Von Herrath M.G., Oldstone M.B. J. Exp. Med. 185:1997;531-539.
7. Grimble R.F. Curr. Opin. Clin. Nutr. Metab. Care. 5:2002;551-559.
8. Springer T.A. Cell. 76:1994;301-314.
9. Dorner B.G., Scheffold A., Rolph M.S., Huser M.B., Kaufmann S.H., Radbruch A.et al. Proc. Natl. Acad. Sci. U.S.A. 99:2002;6181-6186.
10. Zozulinska D., Majchrzak A., Sobieska M., Wiktorowicz K., Wierusz-Wysocka B. Diabetologia. 42:1999;117-118.
11. Buschard K., Diamant M., Bovin L.F., Mansson J.E., Fredman P., Bendtzen K. APMIS. 104:1996;938-944.
12. Bovin L.F., Fredman P., Mansson J.E., Buschard K., Bendtzen K. FEBS Lett. 455:1999;339-343.
13. Mansson J.E., Mo H.Q., Egge H., Svennerholm L. FEBS Lett. 196:1986;259-262.
14. Koshy K., Boggs J. Lipids. 17:1982;998-1000.
15. Kopasczyk K., Radin N. J. Lipid. Res. 6:1965;140-145.
16. Hansen M.B., Svenson M., Diamant M., Bendtzen K. Scand. J. Immunol. 33:1991;777-781.
17. Hochberg Y. Biometrika. 75:1988;800-802.
18. Buschard K., Schloot N.C., Kaas A., Bock T., Horn T., Fredman P.et al. Diabetologia. 42:1999;1212-1218.
19. Kalinski P., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. Immunol. Today. 20:1999;561-567.
20. Buschard K., Horn T., Aaen K., Josefsen K., Persson H., Fredman P. Diabetologia. 39:1996;658-666.
21. Buschard K., Josefsen K., Hansen S.V., Horn T., Marshall M.O., Persson H.et al. Diabetologia. 37:1994;1000-1006.
22. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Science. 259:1993;87-91.
23. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Am. J. Physiol. Endocrinol. Metab. 280:2001;745-751.
24. Muller S., Martin S., Koenig W., Hanifi-Moghaddam P., Rathmann W., Haastert B.et al. Diabetologia. 45:2002;805-812.
25. Xu H., Hirosumi J., Uysal K.T., Guler A.D., Hotamisligil G.S. Endocrinology. 143:2002;1502-1511.
26. Spranger J., Kroke A., Mohlig M., Hoffmann K., Bergmann M.M., Ristow M. et al. Diabetes. 52:2003;812-817.
27. Menten P., Wuyts A., Van Damme J. Cytokine Growth Factor Rev. 13:2002;455-481.
28. Vos J.P., Lopes-Cardozo M., Gadella B.M. Biochim. Biophys. Acta. 1211:1994;125-149.